Medicine
Trospium 60 mg extended-release capsule
Trospium 60 mg extended-release capsule is a generic prescription medicine for oral use, made by 8 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C…
Key facts
- Active ingredient (INN)
- Trospium
- Brand
- Sold under the generic name
- Strength
- 60 mg
- Dosage form
- Extended-release capsule
- Route
- Oral
- Packs
- 30 capsules, 500 capsules, 100 capsules and 14 more
- Manufacturers
- Granules IndiaIndiaProficient RxBryant Ranch PrepackActavis PharmaBluePoint LaboratoriesGolden State Medical SupplyPadagisSlate Run Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F) Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- G04BD09 Trospium
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 12 October 2012
- Identifiers
- RxCUI 857564DailyMed set ID 8e5e2b3a-467b-4312-9778-8ff2ce938838, 5c088397-f407-4606-95a0-d9fe619888c3, 2f431dd1-e130-45e5-a796-1662f498585e +7NDC 60429-098, 70010-027, 63629-8458 +7Application ANDA091289, ANDA213185, ANDA201291 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 capsule, extended release in 1 bottle | 70010-027-03 | Granules IndiaIndia | 19 August 2020 |
| 500 capsule, extended release in 1 bottle | 70010-027-05 | Granules IndiaIndia | 19 August 2020 |
| 30 capsule, extended release in 1 bottle, plastic | 0591-3636-30 | Actavis Pharma | 12 October 2012 |
| 30 capsule, extended release in 1 bottle | 0574-0118-30 | Padagis | 7 June 2013 |
| 30 capsule, extended release in 1 bottle | 70436-174-04 | Slate Run Pharmaceuticals | 21 June 2021 |
| 30 capsule, extended release in 1 bottle | 63629-8458-1 | Bryant Ranch Prepack | 9 February 2022 |
| 30 capsule, extended release in 1 bottle | 71335-2931-1 | Bryant Ranch Prepack | 21 October 2025 |
| 100 capsule, extended release in 1 bottle | 72162-1106-1 | Bryant Ranch Prepack | 13 September 2023 |
| 30 capsule, extended release in 1 bottle | 72162-1106-3 | Bryant Ranch Prepack | 13 September 2023 |
| 30 capsule, extended release in 1 bottle | 68001-427-04 | Bluepoint Laboratories | 10 July 2020 |
| 30 capsule, extended release in 1 bottle, plastic | 60429-098-30 | Golden State Medical Supply | 18 July 2014 |
| 100 capsule, extended release in 1 bottle | 71205-917-00 | Proficient Rx | 8 July 2021 |
| 30 capsule, extended release in 1 bottle | 71205-917-30 | Proficient Rx | 8 July 2021 |
| 500 capsule, extended release in 1 bottle | 71205-917-55 | Proficient Rx | 8 July 2021 |
| 60 capsule, extended release in 1 bottle | 71205-917-60 | Proficient Rx | 8 July 2021 |
| 120 capsule, extended release in 1 bottle | 71205-917-72 | Proficient Rx | 8 July 2021 |
| 90 capsule, extended release in 1 bottle | 71205-917-90 | Proficient Rx | 8 July 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 28 May 2004 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Trospium
Clinical summary
Trospium is a cholinergic muscarinic antagonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency. It is available as tablets and extended-release capsules for oral use. MedsAcross supplies Trospium for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TrospiumFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- TROSPIUM CHLORIDE prescribing information (Granules India) · U.S. National Library of Medicine, DailyMed
Need Trospium 60 mg extended-release capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.